Joint workplaces with the University Hospital Brno - workplaces of the Bohunice and Mater. Hospital
Address: | Jihlavská 340/20, 625 00 Brno, Pavilion L |
---|
phone: | +420 523 233 007 |
---|---|
e-mail: |
Total number of publications: 329
Articles
-
Doporučení ESC pro léčbu akutních koronárních syndromů 2023
cor et Vasa, year: 2024, volume: 66, edition: 2, DOI
-
Doporučený postup diagnostiky a léčby chronické hepatitidy D Datum vydání doporučení: 2023
Klinicka Mikrobiologie a Infekcni Lekarstvi, year: 2024, volume: 29, edition: 3 (Suppl.)
-
Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024
Influenza and Other Respiratory Viruses, year: 2024, volume: 18, edition: e13360, DOI
-
Early Enzymatic Burn Debridement: Results of the DETECT Multicenter Randomized Controlled Trial
JOURNAL OF BURN CARE & RESEARCH, year: 2024, DOI
-
EEG Microstates in Mood and Anxiety Disorders: A Meta-analysis
BRAIN TOPOGRAPHY, year: 2024, volume: 37, edition: 3, DOI
-
EEG-Meta-Microstates: Towards a more objective use of resting-state EEG microstate findings across studies
BRAIN TOPOGRAPHY, year: 2024, volume: 37, edition: 2, DOI
-
Effect of exercise-based cancer rehabilitation via telehealth: a systematic review and meta-analysis
BMC Cancer, year: 2024, volume: 24, edition: 1, DOI
-
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023
EUROSURVEILLANCE, year: 2024, volume: 29, edition: 3, DOI
-
Effects of home-based exercise with telehealth guidance in lymphoma cancer survivors entering cardio-oncology rehabilitation: rationale and design of the tele@home study
CARDIO-ONCOLOGY, year: 2024, volume: 10, edition: 1, DOI
-
Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
Haematologica, year: 2024, volume: 109, edition: 3, DOI